Journal article
Tissue factor pathway inhibitor: New insights into an old inhibitor
Seminars in Thrombosis and Hemostasis, Vol.38(02), pp.129-134
2012
Abstract
Blood coagulation in vivo is triggered by the tissue factor (TF) pathway. The major physiological regulator of this pathway is tissue factor pathway inhibitor (TFPI), a Kunitz-type inhibitor that regulates the activity of the TF-factor VIIa complex in a factor Xa-dependent manner, thus controlling the generation of thrombin and ultimately, fibrin. Although some of the in vivo and in vitro effects of TFPI have been described for nearly a century, the bulk of the research that has elucidated the physiology of this inhibitor has only occurred in the past 25 years. Despite this, many questions remain. This review will highlight the recent advances in knowledge related to TFPI, with an emphasis on new insights into its physiology, association with disease, and possible use as a therapeutic anticoagulant.
Details
- Title
- Tissue factor pathway inhibitor: New insights into an old inhibitor
- Authors/Creators
- M. Adams (Author/Creator) - University of Tasmania
- Publication Details
- Seminars in Thrombosis and Hemostasis, Vol.38(02), pp.129-134
- Publisher
- Thieme Publishing
- Identifiers
- 991005541974207891
- Murdoch Affiliation
- Murdoch University
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
28 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Citation topics
- 1 Clinical & Life Sciences
- 1.75 Blood Clotting
- 1.75.1434 Coagulation Pathways
- Web Of Science research areas
- Hematology
- Peripheral Vascular Disease
- ESI research areas
- Clinical Medicine